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Abstract 
Background:  Chronic rhinosinusitis (CRS) has been linked to the gram-positive bacteria 
Staphylococcus aureus (S. aureus) in its biofilm or intracellular forms. Recent evidence 
suggests that S. aureus also exists in a small colony variant (SCV) form as a mechanism of 
altering its virulence capabilities. The aim of this study was to investigate the presence of 
SCVs in sinonasal mucosa of CRS patients and whether the phenomenon of phenotype 
switching can be applied to intracellular epithelial infections. 
Methods: Sinonasal specimens were examined for the presence of intramucosal S. aureus and 
characterised to the strain level. An airway epithelial cell culture infection model was utilised 
to investigate whether bacteria were capable of alterations in virulence phenotype. 
Results: Intramucosal organisms harvested from sinonasal biopsies demonstrate phenotypic 
growth patterns and lack of coagulase activity consistent with SCVs. Intracellular infection of 
airway epithelial cell cultures with S. aureus led to decreased secretion of enterotoxins and 
phenotypic growth alterations consistent with SCVs. 
Conclusions: Regulation of S. aureus virulence factors is a dynamic process and exposure to 
the intracellular environment appears to provide the necessary conditions to enable these 
alterations in an attempt for the bacterium to survive and persist within host tissues. Further 
work is required to ascertain whether SCVs in CRS hold a clinically relevant pathogenic role 
in recalcitrant disease. 
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Chronic rhinosinusitis (CRS) is characterized by mucosal inflammation affecting the nose 
and paranasal sinuses with a prevalence of between 10-15% (1) and costs of US$5.8 billion 
per annum (2). Relapses are common despite ever evolving medical and surgical therapy 
(3)(4). Bacterial infections, in particular those mediated by Staphylococcus aureus (S. 
aureus), are believed to hold an important role in the recalcitrant nature of this condition with 
frequent relapses attributed to S. aureus in planktonic, biofilm and intracellular phenotypes 
(5, 6). Previous work has demonstrated that S. aureus is detectable both intramucosally (7, 8) 
and intracellularly (9, 10) using different techniques including indirect 
immunohistochemistry (9, 10) or molecular probes and confocal scanning laser microscopy 
(CSLM) (7, 11). The association between bacterial biofilms, activation of specific 
intracellular bacterial pattern recognition receptors (12) and with intracellular status in CRS 
has been noted (11), with significantly more frequent relapses in disease being recognised 
when both the biofilm and intracellular organisms were found within ex vivo tissue samples 
(6). Similar relapsing and remitting patterns have been noted in other diseases mediated by S. 
aureus such as chronic osteomyelitis (13), endocarditis (14) and cystic fibrosis (15). 
A Small Colony Variant (SCV) is a bacterial phenotype that, per definition, grows in smaller 
colonies than their wild-type or planktonic counterparts (16) and have been shown to have the 
ability to survive within Nasal Polyp Epithelial cells in vitro (7). They express alterations in 
pathogenic factors including heightened expression of Fibronectin Binding Proteins (17) and 
reduction of alpha-toxin production (18), which facilitates access and persistence within the 
intracellular milieu. The association between chronic diseases and SCVs is one that has been 
examined in recent years and related to conditions such as osteomyelitis and cystic fibrosis 
(16). The conversion of bacteria from wild-type to SCV and vice versa is a highly dynamic 
process that can occur after days or even hours of exposure to an altered environment.  
S. aureus exhibits its virulence through a number of factors including the secretion of 
staphylococcal enterotoxins (SE) (19). These superantigenic toxins have the capability of 
bridging and bypassing the specific antibody-antigen complex between Major 
Histocompatibility Complex Class II molecules and the receptors on T-helper cells (19), thus 
stimulating a much larger, non-specific T-cell expansion and related inflammatory response. 
IgE to S. aureus enterotoxins (SE-IgE) is elevated in the serum of patients with asthma and 
with CRS (20, 21). SE proteins could be identified in the tissue of almost 50% of CRS 
patients, specifically those with eosinophilic nasal polyposis (22)(19). It is unknown as to 
whether the production of these toxins is a constant or dynamic process, and thus in this study 
we examined whether enterotoxin secretion can change through exposure of S. aureus to 
different environments. 
There has been little research examining the role of SCVs in CRS, or whether the 
phenomenon of S. aureus phenotype switching is a concept applicable to intracellular and 
intramucosal infections. In the present study we used a series of in vitro and ex vivo 
experiments in order to identify whether SCVs exist within sinonasal mucosa from patients 
with CRS. Our results indicate that exposure to the intracellular environment causes an 
alteration from the wild-type phenotype to reduce the production of virulence factors in order 






S. aureus strains ATCC 13565 and 14458 were obtained from American Type Culture 
Collection, reference strains for the production of Staphylococcal Enterotoxin A and B 
(SEA/SEB) respectively. Liquid cultures were prepared as described in the supplementary 
information.  
Harvest of intramucosal bacteria from patient tissue specimens 
Ethical approval for tissue collection was granted from the local institution Human Research 
and Ethics Committee. Informed consent was obtained from eligible patients older than 18 
years of age prior to enrolment. Exclusion criteria included active smoking and the use of oral 
corticosteroids for 4 weeks prior to surgery. Sino-nasal tissue was collected from the ethmoid 
sinuses from patients (n=6) undergoing endoscopic sinus surgery for CRS (diagnosis being 
determined according to the guidelines of the European Position Paper on CRS (23)) and 
placed in Dulbecco’s Modified Eagle’s Medium (Gibco, Invitrogen Corp., Carlsbad, CA). 
Patient demographic factors and sample processing are specified in the supplementary 
information.   
Superantigen detection 
Enterotoxins were detected using the 3M TECRA SIDVIA kit (3M, North Ryde, NSW, 
Australia) following the manufacturer’s instructions, as detailed in supplementary 
information.  
Clonal typing 
Swabs of S. aureus were sent to PathWest Laboratory (Perth, Western Australia, Australia) 
for molecular typing using Pulsed Field Gel Electrophoresis (PFGE) as described (24).  
Methods for the isolation of S. aureus clinical isolates, cell culture infection, 
Immunofluorescence, S. aureus RNA isolation, qRT-PCR,  Lactate Dehydrogenase (LDH) 




Intramucosal S. aureus harvested from sinonasal tissue samples demonstrate small colony 
variant growth patterns 
We used immunofluorescent staining to identify intramucosal S. aureus cocci in 6 CRS 
patients. S. aureus specific bright green fluorescing dots could be identified within the 
sinonasal mucosa, both within and beneath the epithelial layer (Figure 1). Clear morphologic 
differences in terms of colony size and colour could be seen between the bacteria harvested 
from surface tissue swabs and those harvested from tissue homogenates from these patients. 
Sinonasal tissue swabs grew numerous bacterial colonies on blood agar plates after 48 hours 
with a normal phenotype, characterised by yellow pigmentation and weak hemolysis (Fig. 
2A). After disinfecting the tissue, we were unable to culture any bacteria from further tissue 
swabs. However, upon homogenisation of tissue samples we noted the growth of small and 
very small sized non-pigmented, non-hemolytic colonies of S. aureus after 48 hours (Fig. 
2B). When these colonies were immediately plated onto chromogenic agar, they 
demonstrated a lack of coagulase activity, a hallmark of the SCV phenotype (25) (Fig. 2C). 
Colony sizes were measured using ImageJ and a statistically significant difference in size was 
noted (p < 0.0001, unpaired t-test) (Fig. 2D). Intramucosal colonies that were subcultured 
overnight in nutrient broth and then plated onto blood agar demonstrated a return to normal 
colony growth patterns. Swabs of surface, intramucosal and sub-cultured intramucosal 
colonies were sent for microbiological analysis that identified the bacterial species and genus 
as S. aureus. In order to confirm that the differing growth patterns could not be attributed to 
strain divergence, PFGE was performed, demonstrating that the strains of S. aureus cultured 
held an identical genotype, despite the marked difference in growth patterns (Fig. 2E). 
S. aureus strains downregulate virulence factors upon internalisation into epithelial cells 
Reference strains S. aureus ATCC 13565 and ATCC 14458 both expressed the appropriate 
enterotoxin gene, detected using qRT-PCR and secreted the respective SEA or SEB toxin 
when cultured into nutrient broth for 24 hours (results not shown). These strains were then 
used to infect HBE’014 cells. Culture supernatants from flasks of purely intracellular infected 
cells did not demonstrate any bacterial growth when plated onto agar (Fig. 3A). However, 
when the same cellular monolayer was lysed and plated onto agar, it grew numerous colonies 
of bacteria (Fig. 3B). These results indicate that a one hour exposure of the epithelial cells to 
S. aureus enabled the bacteria to enter the cells and that they stayed viable within the 
intracellular compartments. Also, the lysostaphin/gentamycin treatment could effectively 
eliminate all extracellular bacteria while leaving the intracellular bacteria unaffected. Control 
cell cultures that were infected with S. aureus and did not get a lysostaphin/gentamycin 
treatment demonstrated significant bacterial growth in the culture supernatant (Fig. 3C). 
These were clonally typed by PFGE, confirming that they were the same strain as that used to 
inoculate the cultures (results not shown).  
In the absence of any SEA-positive (ATCC 13565) extracellular bacteria, after 24 hours of 
intracellular infection we were unable to detect SEA in either the culture supernatant (Fig. 
3D) or cell lysate (Fig. 3E) of intracellular infected cells compared to detectable SEA in the 
supernatant of extracellular S. aureus flasks (Fig. 3F). In order to determine if this phenotype 
switching of intracellular S. aureus was reversible, bacteria harvested from the intracellular 
infected monolayer were cultured in nutrient broth overnight. Analysis of the broth 
demonstrated SEA to be present, indicating that SEA secretion was switched back on by 
exposure to the different environment. Conversely, infection with the SEB reference strain 
ATCC 14458 demonstrated evidence of SEB within the cell lysate and culture supernatants 
of both intracellular and extracellular flasks suggesting that the bacteria were unable to 
downregulate their toxin production. Using the semi-quantitative scale, there was more toxin 
detected in the cell lysates of intracellular infected cells as opposed to the corresponding 
culture supernatant (Fig. 3G-I).  
Enterotoxin production in clinical isolates 
Six S. aureus clinical isolates were cultured from 6 CRS patients and analysed for expression 
of enterotoxin genes using qRT-PCR to identify that one strain expressed the SEA gene and 
another expressed the SEB gene (results not shown). Analysis using the TECRA kit 
demonstrated that the respective toxins were produced when the isolates were placed in liquid 
culture overnight at 37°C. When these strains were used to infect HBE’014 monolayers, the 
cell lysates or supernatants showed no detectable toxins. Conversely, toxins were found in the 
supernatants of extracellular infected flasks. This indicates that clinical isolates that contain 
enterotoxin genes are capable of “switching off” their production of toxins upon entering the 
intracellular environment. Interestingly, both strains appeared able to switch off their toxin 
production, as opposed to only one of the reference strains, suggesting that these clinical 
isolates had adapted the capacity to downregulate their virulence as a mechanism to persist 
within the cellular environment. 
S. aureus does not cause significant cellular toxicity after internalisation and develops a SCV-
like growth pattern 
After HBE’014 cells were infected with S. aureus ATCC 13565, cell culture media was 
changed daily and IL-6 measured using Enzyme-Linked Immunosorbent Assay (ELISA). The 
IL-6 level in the culture supernatant of cells infected with S. aureus was significantly higher 
than control cells (2.24 fold increase, p=0.0002, unpaired t-test) on day 1 after infection (Fig. 
4A). However, at subsequent time points up to 6 days after initial infection, a modest but 
significant reduction (0.75 fold, p<0.05, unpaired t-test) in IL-6 levels was found in culture 
supernatants of infected cells compared to controls. This indicates that HBE’014 cells react 
when challenged with S. aureus by secreting the pro-inflammatory factor IL-6, as expected, 
but that the intracellular bacteria do not elicit such a reaction. In order to test for toxic effects, 
we determined LDH levels in the same culture supernatants. When LDH measurements from 
infected cell cultures were analysed (Fig. 4B) against negative control cultures there were no 
significant differences at any time point. Cell lysates cultured on blood agar confirmed 
intracellular bacterial presence throughout the experiments and demonstrated phenotypic 
growth pattern changes from normal colony sizes at day 0-2, to SCV-like colonies identified 
after 3 days (Fig. 4C-D). 
Discussion 
Here, we showed that the bacterial phenotype of intramucosal S. aureus harvested ex vivo 
from human sinonasal tissue specimens is indicative of a SCV and have an identical clonal 
type as their extracellular counterparts despite variation in growth patterns. Studies have 
described SCV growth from tissue homogenates previously (26), however our methodology 
employs a series of steps that aims to eliminate surface bacterial contaminants including 
biofilms, and demonstrated the elimination of any surface bacterial growth post-treatment. In 
studies that homogenise whole tissue samples without surface cleansing, it is possible that 
these bacteria were cultured from surface biofilms, as decreased metabolic rate and growth is 
also a hallmark of the biofilm phenotype (27). Biofilms are known to play a role in CRS (28) 
and the phenotypic form of bacteria that reside and form a biofilm could even be that 
resembling a SCV, a hypothesis that could account for their altered growth and antibiotic 
resistance patterns (29). This is an area that would benefit from further investigation. 
We have demonstrated through our in vitro experiments that enterotoxin production can be 
downregulated after only 24 hours of exposure to the intracellular environment. This may 
represent the bacterium altering its pathogenic capacity so as to reduce the toxic effects to the 
cell and thus maintain its protective environmental niche. Interestingly, after infecting cell 
cultures with SEA and SEB producing clinical isolates, both strains downregulated their 
virulence state by reducing the production of SEA and SEB respectively. Conversely, the 
SEB reference strain was unable to reduce its enterotoxin production such that SEB was 
detected within the cell lysate and supernatant after internalisation. This suggests that the 
ability to alter the virulence state may be an important factor in achieving the indolent 
infection. The mechanism by which organisms sense and respond to their environmental 
pressures remains poorly understood. One factor that has been described as a potential 
mechanism is known as the “bet-hedging strategy” (30). In this, it is thought that sub-
population variations in phenotypic expression may be selectively pressured into emergence 
through factors such as antibiotic treatment. This may occur as a means for overall species 
survival in the face of hostile environments.  
When we performed intracellular infections with durations of up to 7 days, it was interesting 
to see that although the internalisation of the organisms caused an initial inflammatory 
response (IL-6 production), this was rapidly reduced. The initial stimulation supports the 
findings of Sachse et al. (7), however, in this study the authors did not make any further 
supernatant recordings beyond a 12 hour time-point. This initial IL-6 secretion could be 
induced by a TLR2-dependent immune response occurring through the extracellular insult as 
reported (31). The fact that there was no significant increase in LDH at any time point 
suggests that despite this inflammatory insult, it did not lead to any additional toxicity.  
Importantly, whereas our in vitro cell culture model indicates that S. aureus undergoes 
phenotypic changes upon invasion of epithelial cells, no definitive conclusions can be drawn 
on the relevance of this finding in vivo. Indeed, fundamental differences between in vitro cell 
culture models and the in vivo situation exist. These include the non-physiological conditions 
that cells are cultured in vitro or that pathogens are applied to the cells, the presence of only a 
single cell type and the lack of efficient intercellular communication (32).  
In conclusion, our results strengthen the hypothesis that intracellular S. aureus in CRS have a 
SCV phenotype, and subvert the host immune response by different mechanisms. These 
include the abortion of a pro-inflammatory immune response, absence of toxic effects and a 
reversible switching of bacterial virulence factors. Regulation of S. aureus virulence factors is 
a dynamic process dependant on environmental factors; specifically, the intracellular milieu 
appears to provide the necessary pressures to cause these alterations in an attempt for the 
bacterium to survive and persist within host tissues. The SCV hypothesis is one that is 
applicable to bacterial persistence in CRS, strengthened by evidence from their retrieval 
within mucosal homogenates. Further investigation is required to ascertain whether SCVs in 
CRS hold a clinically relevant pathogenic role in recalcitrant disease.  
  
Figure Legend 
Figure 1. Immunofluorescence of sinonasal mucosal tissue in CRS.  
A: Negative control slide; B-C: Immunofluorescent images from two representative 
intramucosal S. aureus positive CRS patients. Brightly fluorescent S. aureus stained in green 
located mainly within (B, see insert) or within and beneath (C, see insert) the cytokeratin-
positive epithelium (in red). 20 X magnification. 
 
 
Figure 2: Small Colony Variants in CRS mucosal samples 
A-B: Horse blood agar plates incubated at 37°C for 48 hours and inoculated with; A: surface 
tissue swabs of sinonasal mucosa demonstrating a mixed population of normal sized and 
small colonies of S. aureus with the characteristic yellow colour; B: sinonasal mucosal tissue 
homogenate post disinfection of surface bacteria demonstrating a population of small and 
very small colonies of S. aureus, whitish in colour; C: intramucosal colonies subcultured onto 
chromagenic agar demonstrating lack of coagulase activity.  
D: Comparison of colony size retrieved from tissue swab versus sinonasal mucosal tissue 
homogenate. Bars represent mean +/- standard error of the mean (SEM) (*** p < 0.0001, 
unpaired t-test). 
E: Pulse Field Gel Electrophoresis dendrogram demonstrating differing inter-individual 
clonal types of S. aureus harvested from surface tissue swabs from two different CRS 
patients (1A/2A). These clonal types were identical within the same individual when isolated 
from intramucosal small colonies (1B/2B) and subcultured intramucosal colonies (1C/2C). 
Vertical bars demonstrate fragments of bacterial DNA cut by restriction enzymes. 
 
 
Figure 3: Staphylococcal enterotoxin detection from in vitro infection experiments 
A-C:  Horse blood agar plates grown overnight at 37°C inoculated with; A: culture media 
from HBE’014 cell flasks intracellularly infected with S. aureus ATCC 13565 demonstrating 
the absence of viable bacteria; B: HBE’014 cell monolayer lysed in water 24 hours post 
infection with ATCC 13565 demonstrating presence of intracellular bacteria; C: extracellular 
culture media infected with ATCC 13565 demonstrating significant bacterial growth. 
D-I:  3M TECRA Staphylococcal enterotoxin A (SEA) and B (SEB) identification test; 
experiments using ATCC 13565 (SEA, D-F (black)); experiments using ATCC 14458 (SEB, 
G-I (blue):); D/G: culture media from intracellular infected epithelial cells demonstrating 
reduced production of SEA but not SEB; E/H: cell lysates of intracellular infected epithelial 
cells demonstrating reduced production of SEA but not SEB; F/I: culture media from 
extracellular infected epithelial cells demonstrating evidence of SEA and SEB. 
 
 
Figure 4: Effects of long-term intracellular infection with S. aureus ATCC 13565 on 
airway epithelial cells. 
A: IL-6 ELISA of culture media post intracellular infection demonstrating a statistically 
significant rise on day 1 followed by a reduction to levels lower than non-infected cells at 
subsequent time points up to day 6; *, P < 0.05; **, P < 0.01; ***, P < 0.001; unpaired t-test. 
B: Lactate Dehydrogenase (LDH) measurements of culture media post intracellular infection 
demonstrating no significant difference compared to non-infected cells. Bars for A/B 
represent mean +/- standard error of the mean (SEM);  
C/D: Intracellular colonies retrieved from epithelial monolayer; C: Day 3 post infection 
demonstrating mixed population of normal and small colonies; D: Day 6 post infection 
demonstrating several small colony variants, characterized by tiny (pinpoint) non-pigmented 
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Supplementary Table 1: Patient demographic factors 
Patient Age Airway 
Allergies 










3 82 Allergic Noninsulin-dependent 
diabetes mellitus, 
hypertension. 









Asthma. Alendronate, Mometasone 
Furoate, Pantoprazole 




Isolation of S. aureus clinical isolates from tissue homogenates 
 Mucosal samples were swabbed and then soaked in 0.03% cetylpyridinium chloride 
(CPC; Sigma-Aldrich) for 10 minutes. After washing three times with laboratory 
grade ultra pure water (UPW), samples were swabbed, immersed in phosphate 
buffered saline (PBS) and placed into a waterbath sonicator at medium intensity for 
15 minutes. The sonicated tissue was swabbed, soaked again in 0.03% CPC for 10 
minutes, re-swabbed, washed in UPW, homogenised using a Tissueruptor (Qiagen, 
GmbH, Hilden, Germany) and cultured on blood agar plates at 37
O
C for up to 72 
hours and experiments performed in duplicate. The diameter of 25 individual colonies 
was measured using ImageJ software (National Institutes of Health, Bethesda, 
Maryland, USA).  
Bacterial strains 
Liquid cultures were prepared by inoculating 5ml of nutrient broth with a single loop 
of bacteria and placed into a shaking incubator overnight at 120 rpm and 37°C. The 
liquid culture was centrifuged at 4000 rpm for 10 minutes and the supernatant 
collected, filtered and cryopreserved at -80 °C. Bacterial pellets were used for 
infection experiments or RNA analysis. Clinical isolates were obtained through 
routine microbiological swabs taken from patients at the time of endoscopic sinus 
surgery. S. aureus positive cultures were isolated and sub-cultured in nutrient broth 
before being cryopreserved at -80 °C.  
 
Cell culture infection model 
Human Bronchial Epithelial cells (16HBE14o-HBE’014) were a kind gift from Dr 
Dieter Gruenert and cultured in Minimum Essential Medium (MEM) supplemented 
with 10% fetal calf serum (FCS), 1% L-Glutamine and 1% penicillin / streptomycin 
(Gibco, Carlsbad, CA). Cells were washed in PBS and incubated for one hour with 
5.0 McFarland units S. aureus (multiplicity of infection (MOI) of 100:1). The cells 
were then washed three times in PBS, incubated with media containing 4ug/ml 
lysostaphin for 30 minutes, washed 3 times in PBS and incubated in MEM 
supplemented with 10% FCS, 1% L-Glutamine and 100 µg/ml gentamicin. Control 
cells were inoculated with S. aureus but lysostaphin/gentamycin treatment was 
omitted. After 24 hours, culture supernatants were collected and cells were washed 




Bacterial pellets from overnight liquid cultures were resuspended in RNALater 
(Ambion, Carlsbad, CA) and stored overnight at 4
O
C.   This was centrifuged at 4000 
rpm for 10 minutes and the bacterial pellet lysed in Tris-EDTA (TE) buffer containing 
lysostaphin at 500 µg/ml for 1 hour at 37
O
C in a rotary heating block. Into the 
bacterial suspension was added 350 µl of RLT buffer (Qiagen) and 250 µg of acid 
washed glass beads (Sigma-Aldrich, St. Louis, MI). Mechanical lysis was performed 
at 30 beats/second in a Tissueruptor (Qiagen) for 10 minutes.  RNA was purified 
using RNeasy columns (RNeasy Mini Kit, Qiagen) following the manufacturer’s 
instructions and included an on column DNAse treatment (Qiagen). RNA 




Real-time qRT-PCR was performed with RNA isolated from the bacterial strains. 
Firstly, cDNA was produced using the Quantitect RT kit (Qiagen) and qRT detection 
was with the IQ Sybr green supermix (Biorad, Hercules, CA). Oligonucleotide primer 
sequences were as follows; SEA /1F  5’-CCTTTGGAAACGGTTAAAAC-3’; 
SEA/1R 5’-CTCTGMACCTTYCCATCAAA-3’ (34), SEB/1F 5’-
ACACCCAACGTTTTAGCAGAGAG-3’; SEB/1R 5’-
CCATCAAACCAGTGAATTTACTCG-3’ (35). Reactions were heated for 30 
seconds at 95°C followed by 35 cycles of 30 seconds at 95°C and 60 seconds at 60°C.  
All experiments were performed in duplicate using an iQ5 Cycler (Biorad, Hercules, 
CA).   
 IL-6 ELISA 
Human Bronchial Epithelial cells (HBE’014) were seeded into 6 well plates and 
infected as per the previously described protocol. Culture media was changed every 
24 hours and frozen to -80°C for subsequent analysis using IL-6 Enzyme-Linked 
Immunosorbent Assay (ELISA) and Lactate Dehydrogenase (LDH) assay. 
Comparison was made to negative controls that had daily media changes with no S. 
aureus infection. All experiments were performed in triplicate. 
A sandwich ELISA technique was carried out to detect IL-6 protein expression in cell 
supernatants. Briefly, ELISA plates were coated overnight with rat anti-human 
capture antibody (BD Biosciences, California, USA), diluted in 0.1 M NaHCO3, at 
4°C. After washing with PBS containing 0.05% tween-20 (Sigma-Aldrich), plates 
were incubated with blocking buffer (PBS containing 2% bovine serum albumin 
(Sigma-Aldrich)) for 2 hours at room temperature. Samples and standard 
concentrations (BD Biosciences) were applied to the wells in duplicates and incubated 
at room temperature for another 2 hours. After washing, biotinylated rat antihuman 
IL-6 antibody (BD Biosciences) was added and incubated at room temperature for 30 
minutes. After washing, Horseradish Peroxidase (HRP)-conjugated streptavidin 
(Thermo Scientific, Australia) was incorporated and incubated at room temperature 
for 30 minutes. TMB (3,3′,5,5′-Tetramethylbenzidine) substrate solution (Thermo 
Scientific, Australia) was applied and the reaction stopped with 0.16 M sulphuric acid 
after 10 minutes. Light absorbance was measured at 450 nm using spectrometry. The 
values obtained were corrected by dilution factor and expressed in pg/ml. The lower 
limit of detection was 12.5 pg/ml.  
 Lactate Dehydrogenase (LDH) Assay 
Culture supernatants were centrifuged then passed through a 0.22 µm filter before 
being processed by a commercially available LDH assay (CytoTox 96® Non-
Radioactive Cytotoxicity Assay, Promega, Madison, WI) as per the manufacturer’s 
instructions. Briefly, in a 96 well plate, 50 µl of filtered supernatant was mixed with 
50 µl of substrate mix and incubated for 30 minutes at room temperature. The 




Briefly, supernatants and cell lysates were centrifuged at 13,300 g for 10 minutes 
before being passed through a 0.2 µm filter and 200 µl was added to 10 µl of buffer 
solution. Wells were pre-soaked with wash solution for 30 minutes followed by 
incubating 50 µl of supernatant or lysate for 2 hours at 37°C. Following washing, 200 
µl of substrate solution was added and incubated for 1 hour and then washed again. 
200 µl of conjugate was added and the plate read after 30 minutes. The 3M TECRA 
SIDVIA kit (3M, North Ryde, NSW, Australia) uses a visual assessment that either 
classifies a sample as enterotoxin positive or negative with a sensitivity of 1 ng/ml. 
 
Indirect immunofluorescence 
Antibodies used were a mouse IgM monoclonal antibody to S. aureus (Millipore, 
Billerica, MA) and a rabbit polyclonal anti-human pan-cytokeratin (Invitrogen Corp., 
Carlsbad, CA). Negative controls were prepared with normal rabbit IgG (Sigma-
Aldrich, St. Louis, MI). Secondary antibodies were goat anti-mouse IgM-Alexa488 
(Invitrogen Corp., Carlsbad, CA) and sheep IgG F(ab′) anti-rabbit IgG-Cy3 (Sigma-
Aldrich, St. Louis, MI). Indirect immunofluorescence of paraffin embedded tissue 
sections was carried out following a previously described protocol (33). Briefly, 5 μm 
sections were prepared from paraffin embedded tissue blocks, mounted on glass 
microscope slides (Superfrost, Thermo Fisher, Waltham, MA), deparaffinised and 
rehydrated using xylene and graded ethanol. Slides were immersed in 10 mM sodium 
citrate and antigen retrieval performed using a microwave technique. Slides were 
transferred into a Tris-buffered saline buffer containing 0.05% of Tween-20 (TBST). 
Serum free protein block (SFB) (Dako, Glostrup, Denmark) was applied for 1 h at 
room temperature and slides were incubated simultaneously with mouse anti-S. 
aureus and rabbit anti-pan-cytokeratin antibodies overnight at 4 °C. Slides were 
washed in TBST and secondary antibodies were applied for 1 h at room temperature 
in a darkened moisture chamber. Slides were washed in TBST and coverslips 
mounted in 90% glycerol for microscope analysis with a Zeiss Axio Vert.A1 (Carl 
Zeiss AG, Jena, Germany).  
 
Statistical analysis 
To determine differences in colony size, IL-6 and LDH concentrations, statistical 
analysis was performed with Graphpad Prism 6.0 software (San Diego, CA) using an 
unpaired t-test and statistical significance was obtained when p < 0.05.  
  
 
